With advances in genetic testing and personalised medicine, there is growing debate over whether health insurance companies should have access to individuals’ genetic profiles. While some believe this information can help create fair and efficient insurance systems, others argue that such practices would result in discrimination and unfair treatment. This essay will discuss both perspectives before presenting my own view.
On the one hand, supporters of sharing genetic data with insurers argue that it enables more accurate premium calculation. If insurance companies know a person’s likelihood of developing certain illnesses, they can assess financial risks more precisely and allocate resources more efficiently. For instance, individuals at low genetic risk might pay lower premiums, which could encourage healthy lifestyles and reward those who are less likely to burden the healthcare system. Moreover, access to genetic information could also motivate insurers to invest in preventive healthcare programmes, ultimately reducing long-term medical costs for society.
On the other hand, opponents believe this practice would lead to genetic discrimination and damage social equality. People who happen to be genetically predisposed to certain conditions, such as heart disease or cancer, may face significantly higher premiums or even denial of coverage, regardless of their actual lifestyle or current health. This could create a society where individuals are punished for biological factors they cannot control. Furthermore, such policies may discourage people from undergoing genetic tests due to fear of financial consequences, which could hinder medical research and early disease detection – both crucial aspects of modern healthcare.
In my opinion, the risks associated with allowing insurance companies access to genetic information outweigh the benefits. Health insurance should be based on the principles of fairness and social support, not genetic fortune. While personalised insurance may appear efficient, it would ultimately create a system that disadvantages vulnerable individuals and discourages medical progress. Instead, genetic data should remain strictly confidential, and governments should introduce strong regulations to protect citizens from misuse of sensitive health information.